An improved method for measurement of target-to-Background ratio in assessing mediastinal lesions on 18F-FDG coincidence SPECT/CT imaging

Nuclear Medicine Communications

Volumn 31, Issue 5, 2010, Pages 398-404

  Wang, Peng ^a   Meng, Zhaowei ^a   Tan, Jian ^a   Jia, Qiang ^a   Zhang, Fuhai ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

18F FDG; Dual head coincidence imaging; Mediastinal lesion; Single photon emission computed tomography computed tomography; Target to background ratio

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AIRWAY; ARTICLE; BENIGN TUMOR; BLOOD; BODY FAT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HEART; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; MEASUREMENT; MEDIASTINUM; MEDIASTINUM CANCER; MEDIASTINUM DISEASE; PREDICTION; RADIOLOGICAL PARAMETERS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TARGET TO BACKGROUND RATIO;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951085274     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328336bc4a     Document Type: Article

References (26)

1. Even-Sapir E, Yuzefovich B, Miller E, Bouhnik JP, Zak O, Lerman H, et al. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction. J Nucl Med Technol 2004; 32:190-197. (Pubitemid 47618959)
2. Moodie K, Cherk MH, Lau E, Turlakow A, Skinner S, Hicks RJ, et al. Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT. J Med Imaging Radiat Oncol 2009; 53:32-39.
3. Wang F,Wang Z, YaoW, Xie H, Xu J, Tian L. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging. J Nucl Med 2007; 48:1442-1448.
4. Zhan HW, Cheng HF, Ye XJ, Zhao CL, Zhang H, Liu HB, et al. Evaluation of lung lesions using FDG gamma-camera PET equipped with a one-inch crystal. Oncol Rep 2008; 20:173-178.
5. Li LF, Zhou SH, Zhao K,Wang SQ,Wu QL, Fan J, et al. Clinical significance of FDG single-photon emission computed tomography: computed tomography in the diagnosis of head and neck cancers and study of its mechanism. Cancer Biother Radiopharm 2008; 23:701-714.
6. Tatsumi M, Yutani K, Watanabe Y, Miyoshi S, Tomiyama N, Johkoh T, et al. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET. J Nucl Med 1999; 40:566-573. (Pubitemid 29171797)
7. Zhang H, Inoue T, Tian M, Alyafei S, Oriuchi N, Khan N, et al. A basic study on lesion detectability for hot spot imaging of positron emitters with dedicated PET and positron coincidence gamma camera. Ann Nucl Med 2001; 15:301-306. (Pubitemid 32679231)
8. Zhang H, Tian M, Oriuchi N, Higuchi T, Tanada S, Endo K. Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET. Br J Radiol 2002; 75:409-416. (Pubitemid 34654077)
9. Koga H, Sasaki M, Kuwabara Y, Nakagawa M, Hayashi K, Kaneko K, et al. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. Ann Nucl Med 2004; 18:131-136. (Pubitemid 38856007)
10. Inoue T, Oriuchi N, Koyama K, Ichikawa A, Tomiyoshi K, Sato N, et al. Usefulness of dual-head coincidence gamma camera with thick NaI crystals for nuclear oncology: comparison with dedicated PET camera and conventional gamma camera with thin NaI crystals. Ann Nucl Med 2001; 15:141-148. (Pubitemid 32521925)
11. Stevens H, Bakker PF, Schlosser NJ, van Rijk PP, de Klerk JM. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers. J Nucl Med 2003; 44:336-340. (Pubitemid 39586007)
12. Oturai PS, Mortensen J, Enevoldsen H, Eigtved A, Backer V, Olesen KP, et al. Gamma-camera 18F-FDG PET in diagnosis and staging of patients presenting with suspected lung cancer and comparison with dedicated PET. J Nucl Med 2004; 45:1351-1357. (Pubitemid 47618535)
13. Yutani K, Tatsumi M, Shiba E, Kusuoka H, Nishimura T. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis. J Nucl Med 1999; 40:1003-1008. (Pubitemid 29269222)
14. Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, et al. Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. J Nucl Med 2008; 49:1038-1046. (Pubitemid 351948010)
15. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. (18)F-FDG PET/ CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging 2009; 36:1794-1802.
16. Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, et al. Stage T1 nonsmall cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT - a prospective study. Radiology 2006; 241:501-509. (Pubitemid 44632897)
17. Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA, Maldonado A, Garcia de Barajas S, Calero-Garcia R, et al. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable nonsmall- cell lung cancer. J Clin Oncol 2005; 23:8348-8356. (Pubitemid 46260230)
18. Yap KK, Yap KS, Byrne AJ, Berlangieri SU, Poon A, Mitchell P, et al. Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2005; 32:1033-1040. (Pubitemid 41339278)
19. Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003; 44:1789-1796. (Pubitemid 39663311)
20. Wehrli NE, Bural G, Houseni M, Alkhawaldeh K, Alavi A, Torigian DA. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography. Semin Nucl Med 2007; 37:195-205. (Pubitemid 46517470)
21. Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR Am J Roentgenol 2004; 183:1127-1132.
22. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982; 23:577-586. (Pubitemid 12090912)
23. Hays MT, Segall GM. A mathematical model for the distribution of fluorodeoxyglucose in humans. J Nucl Med 1999; 40:1358-1366. (Pubitemid 29385646)
24. Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl Med 2007; 48:1662-1669. (Pubitemid 47577344)
25. De Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005; 32:98-101. (Pubitemid 40142784)
26. Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990; 31:1749-1756.